These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 12611307

  • 21. [Low-molecular weight heparin in the treatment of pregnant women with high thrombotic risk].
    Todorova K, Mazneĭkova V, Ivanov S.
    Akush Ginekol (Sofiia); 2004; 43(4):46-52. PubMed ID: 15318544
    [No Abstract] [Full Text] [Related]

  • 22. [Use of low molecular weight heparin (Clexane) together with selective COX-2 inhibitor (Dynastat--once or twice per day)].
    Tablov B, Ruseva A, Tablov V, Popov I, Stoĭkov S.
    Akush Ginekol (Sofiia); 2005; 44(5):31-4. PubMed ID: 16313051
    [Abstract] [Full Text] [Related]

  • 23. [Acetylsalicylic acid for thrombosis prevention].
    Frølund F.
    Ugeskr Laeger; 1989 Oct 02; 151(40):2598-9. PubMed ID: 2815367
    [No Abstract] [Full Text] [Related]

  • 24. [Application of clexane in urosepsis: necessity or the issue of fashion].
    Usenko LV, Garmish OS, Zabashnyĭ SI, Stadnichuk GN, Ovchinnikova LIu, Biriukov VV.
    Klin Khir; 2001 Jun 02; (6):54-7. PubMed ID: 11688269
    [Abstract] [Full Text] [Related]

  • 25. [The first oral thrombin inhibitor. Competition to heparins and marcumar?].
    MMW Fortschr Med; 2003 Mar 06; 145(10):56. PubMed ID: 12688030
    [No Abstract] [Full Text] [Related]

  • 26. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C, Nixdorff U, Hofmann T, Lehmacher W, Daniel WG, Hanrath P, Geller C, Mügge A, Sehnert W, Schmidt-Lucke C, Schmidt-Lucke JA, ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group.
    Circulation; 2004 Mar 02; 109(8):997-1003. PubMed ID: 14967716
    [Abstract] [Full Text] [Related]

  • 27. [Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients].
    MMW Fortschr Med; 2006 Jun 08; 148(23):58-9. PubMed ID: 16826742
    [No Abstract] [Full Text] [Related]

  • 28. [Anesthetic management for a patient with anti-phospholipid antigen syndrome].
    Ando Y, Nagano K, Morita S, Itoh H, Fukushima Y.
    Masui; 2009 Aug 08; 58(8):1007-9. PubMed ID: 19702220
    [Abstract] [Full Text] [Related]

  • 29. Biomarkers and coagulation tests for assessing the biosimilarity of a generic low-molecular-weight heparin: results of a study in healthy subjects with enoxaparin.
    Kuczka K, Harder S, Picard-Willems B, Warnke A, Donath F, Bianchini P, Parma B, Blume H.
    J Clin Pharmacol; 2008 Oct 08; 48(10):1189-96. PubMed ID: 18716314
    [Abstract] [Full Text] [Related]

  • 30. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J, Hoppensteadt DA, Fareed D, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R.
    Semin Thromb Hemost; 2008 Feb 08; 34(1):58-73. PubMed ID: 18393143
    [Abstract] [Full Text] [Related]

  • 31. Comparison of fondaparinux, low molecular-weight heparin and unfractionated heparin in preventing thrombus formation on mechanical heart valves: results of an in-vitro study.
    Schlitt A, Hamilton K, Maegdefessel L, Dahm M, Theis C, Eichler M, Brockmann O, Steinseifer U, Hauroeder B, Hitzler WE, Rupprecht HJ.
    J Heart Valve Dis; 2006 Nov 08; 15(6):809-14. PubMed ID: 17152789
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of enoxaparin, a low molecular weight heparin in the prevention of deep vein thrombosis in Nigerian patients after orthopaedic surgery.
    Akanmu AS, Nnodu OE, Giwa SO, Salako LA, Akinsete I, Adebule GT, Adekoya-Cole TO, Odunubi OO.
    Afr J Med Med Sci; 2004 Dec 08; 33(4):335-40. PubMed ID: 15977441
    [Abstract] [Full Text] [Related]

  • 33. Optimal antithrombotic treatment for percutaneous coronary intervention.
    Kadakia RA, Ferguson JJ.
    Minerva Cardioangiol; 2005 Feb 08; 53(1):15-42. PubMed ID: 15788977
    [Abstract] [Full Text] [Related]

  • 34. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR, Mourão PA.
    Thromb Haemost; 2008 Mar 08; 99(3):531-8. PubMed ID: 18327401
    [Abstract] [Full Text] [Related]

  • 35. ["How must deep leg venous thrombosis be diagnosed and treated?"].
    Bruhn HD.
    Dtsch Med Wochenschr; 2003 Aug 15; 128(33):1730-1. PubMed ID: 12920673
    [No Abstract] [Full Text] [Related]

  • 36. The management of lichen planus with low-molecular-weight heparin (enoxaparin).
    Akdeniz S, Harman M, Atmaca S, Yaldiz M.
    Int J Clin Pract; 2005 Nov 15; 59(11):1268-71. PubMed ID: 16236078
    [Abstract] [Full Text] [Related]

  • 37. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
    Tetri S, Hakala J, Juvela S, Saloheimo P, Pyhtinen J, Rusanen H, Savolainen ER, Hillbom M.
    Thromb Res; 2008 Nov 15; 123(2):206-12. PubMed ID: 18420258
    [Abstract] [Full Text] [Related]

  • 38. Influence of simultaneous administration of low-dose heparin and acetylsalicylic acid on blood coagulation and platelet functions.
    Loew D, Vinazzer H.
    Haemostasis; 1974 Nov 15; 3(5-6):319-28. PubMed ID: 4468231
    [No Abstract] [Full Text] [Related]

  • 39. [Correction of intraoperative disorders of hemostasis during aortocoronary bypass in patients with chronic ischemic heart disease].
    Kurochkin VM, Iagudina DN, Soboleva ER, Berdichevskiĭ MS.
    Anesteziol Reanimatol; 1988 Nov 15; (2):21-4. PubMed ID: 3261556
    [No Abstract] [Full Text] [Related]

  • 40. [The coagulation cascade--clinical implications].
    Langer H, Gawaz M.
    Herz; 2005 May 15; 30(3):170-5. PubMed ID: 15902366
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.